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Abstract
Bacterial infection elicits a range of beneficial as well as detrimental host inflammatory responses.
Key among these responses are macrophage/monocyte necrosis, release of the pro-inflammatory
factor high-mobility group box 1 protein (HMGB1), and induction of the cytokine IL-1. While the
control of IL-1β has been well-studied, processes that control macrophage cell death and
HMGB-1 release in animals are poorly understood. This study utilizes Klebsiella pneumonia as a
model organism since it elicits all three responses in vivo. The regulation of these responses is
studied in the context of the inflammasome components, NLRP3 and ASC, which are important
for caspase-1 activation and IL-1β release. Using a pulmonary infection model that reflects human
infection, we show that K. pneumonia-induced mouse macrophage necrosis, HMGB-1 and IL-1β
release are dependent on NLRP3 and ASC. K. pneumoniae infection of mice lacking Nlrp3 results
in decreased lung inflammation and reduced survival relative to control indicating the overall
protective role of this gene. Macrophage/monocyte necrosis and HMGB1 release are controlled
independently of caspase-1 suggesting that the former two responses are separable from
inflammasome-associated functions. These results provide critical in vivo validation that the
physiologic role of NLRP3 and ASC is not limited to inflammasome formation.
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The NLR (nucleotide binding domain, leucine rich repeats-containing) family (formerly
known as CATERPILLER, NOD, NACHT-LRR, NOD-like receptor) family of genes/
proteins is increasingly implicated in the regulation of immunity (1). The NLR family
member NLRP3 (formerly cryopyrin, CIAS1, NALP3), which is expressed abundantly in
neutrophils and macrophages, has emerged as a critical mediator of inflammation. NLRP3/
CIAS1, the human gene encoding this protein, was first identified through its association
with the hereditary periodic fever syndrome, CAPS (CIAS1-associated periodic syndrome),
which comprises a wide range of inflammatory symptoms and severity (2–6). This condition
results from gain-of-function mutations in NLRP3. Disease-associated variant forms of
NLRP3 exhibit enhanced capacity to induce caspase-1 and IL-1β maturation, and a necrotic
pathway of macrophage cell death that indirectly enhances inflammation (7–9).
A role for NLRP3 in caspase-1 maturation is well-studied. Following stimulation, NLRP3,
the adaptor ASC (Apoptotic Speck-like protein containing a Card), Cardinal/TUCAN, and
pro-caspase-1 combine to form one of several known inflammasome complexes. Within this
complex, pro-caspase-1 is activated, which in turn cleaves and activates the pyrogenic
cytokines IL-1β and IL-18 (9). Currently, the inflammasome protein complex has also been
demonstrated for NLRP1 (NALP1), and the function of caspase-1/IL-1β release has been
associated with NLRC4 (IPAF/CLAN) and NAIP5, however activation of the NLRP3
inflammasome is associated with the widest spectrum of stimuli. Among these are gram-
positive and gram-negative bacteria, including Staphylococcus aureus, Listeria
monocytogenes, and Shigella flexneri, toxins as well as uric acid crystals and pathogen or
non-pathogen derived nucleic acid (8, 10, 11). Environmental pollutants such as asbestos
and silica, as well as particulate adjuvants and β-amyloid have also been found to require
NLRP3 for caspase-1 mediated cytokine secretion (12–16)
Recent work has suggested a second pro-inflammatory function for NLRP3 involving
monocyte necrosis (7, 8). Although the study of this process has been previously limited to
in vitro culture, this form of necrosis has been shown to occur in monocytic cells infected
with intracellular bacteria or following exposure to toxins. Both microbial pathogen (S.
flexneri) induced necrosis and necrotic death associated with CAPS require NLRP3, its
partner protein ASC, and the lysosomal protease cathepsin B (8). However, NLRP3-
dependent necrosis is entirely independent of caspase-1 and IL-1β, and other apoptosis-
associated caspases and has been named pyronecrosis. One defining feature of monocytic
necrosis is the loss of plasma membrane integrity and subsequent spilling of intracellular
inflammatory contents, most notably the nuclear factor HMGB1, which elicits strong pro-
inflammatory effects when released into the microenvironment (17). HMGB1 can activate
the RAGE receptor and TLRs to elicit proinflammatory responses including the release of
TNF-α and IL-1β. HMGB1 is considered a therapeutic target as antibodies against HMGB1
have been shown to effectively reduce sepsis, arthritis, and cancer in animals (18–20).
However NLR-dependent inflammatory necrosis or HMGB1 release remain to be validated
in a physiologic setting (21).
Klebsiella pneumoniae is among the most common gram negative bacteria encountered by
clinicians worldwide and is a leading cause of community-acquired and hospital-associated
respiratory infection (22). Its frequency in the latter context is particularly alarming as K.
pneumoniae is responsible for up to 23% of nosocomial infections, and a mortality rate of up
50% in elderly or otherwise compromised patients (23). Moreover, the growing prevalence
of antibiotic resistant strains in this species has led to increased attention and concern (24,
25). K. pneumoniae is a non-motile, non-flagellated, gram negative, rod-shaped bacterium
which normally resides within the mouth, skin, and intestines. Pathogenic K. pneumoniae
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invades the lungs where it is capable of inducing severe bacterial pneumonia that is often
complicated with bacteremia and sepsis (26). Airway infection typically leads to extensive
lung injury resulting from increased inflammation, hemorrhage, and the necrotic destruction
of lung tissue. This process results in thick, blood-laced mucous known as “currant jelly”
sputum, which is characteristic of K. pneumoniae-induced pneumonia. In addition to cellular
necrosis, this bacteria also induces HMGB1 release in humans (27) . Though recent work
has started to identify innate immune mechanisms underlying these diverse host responses to
bacterial infection, little work has been done to examine the regulation of these diverse
inflammatory responses elicited by K. pneumoniae infection, or the contribution of these
mechanisms to pathogenesis or immunity (28–30). Due to the multiple inflammatory
responses that are elicited by K. pneumoniae including cytokines, necrosis and HMGB1
induction, and its potential as a public health threat caused by the rise of antibiotic-resistance
strains, we elected to study the roles of NLRP3 and ASC using this bacteria in animals.
Despite the wealth of in vitro data implicating the NLR family in pathogen-induced
inflammation, in vivo evidence for the importance of these proteins in inflammation has
been limited to IL-1β and IL-18 release. This report shows that NRLP3 activates
macrophage necrosis as well as HMGB1 release in addition to IL-1β/IL-18 secretion in
response to K. pnuemoniae in infected animals. NRLP3 is an important immune protection
factor during infection with this bacteria as its absence decreases the inflammatory response
and the rate of survival in mice. This is the first in vivo analysis depicting an inflammasome-
independent function of NRLP3 which reveals a much broader physiologic role for NRLP3
that extends beyond IL-1β/IL-18 secretion.
Materials and Methods
Experimental Animals
All studies were conducted in accordance with the National Institutes of Health Guide for
the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and
Use Committee of the University of North Carolina at Chapel Hill. Mice deficient in
Nlrp3ASC, Nlrc4, and caspase-1 were generated as previously described (31, 32). All
animals were maintained in pathogen-free facilities at The University of North Carolina at
Chapel Hill.
Cell lines and reagents
THP-1 cells were obtained from American Type Culture Collection (ATCC) and cultured as
described previously (33). Antibodies: anit-caspase-3 from Cell Signaling; anti-PARP, anti-
Actin, and HRP-conjugated secondary antibodies from Santa Cruz Biotechnology; anti-
HMGB1 from Abcam; Super Signal ECL reagent from BioRad. The preparation of
retroviral vectors and THP-1 cell lines stably expressing shRNA has been described (34).
The shRNA target sequences are: shASC-GCTCTTCAGTTTCACACCA, shCtrl-
GCTCTTCctggcCACACCA, shNLRP3-GGATGAACCTGTTCCAAAA.
Bacteria
K. pneumoniae 43816, serotype 2 was obtained from the ATCC and cultured in LB. Bacteria
density was estimated by measuring the absorbance at 600 nm (1 OD600 = 3 × 108 bacteria/
ml). Accurate CFUs were determined for each experiment by plating an aliquot on LB agar
plates.
Bacterial induced inflammation
Cultures of K. pneumoniae were pelleted, washed twice in PBS, and resuspended in PBS.
Mice were anesthetized and challenged via intratracheal (i.t.) instillation with 7.4 × 104
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CFUs of K. pneumoniae in 50 µl of PBS, as previously described (28). Mock challenged
mice received 50 µl of PBS. THP-1 cells were infected with Klebsiella at a MOI=50 for 6
hours. Bone marrow derived macrophages (BMDM) were prepared as previously described
(8) and infected with Klebsiella (MOI=200, 6 hours) or Salmonella (MOI=50, 1 hour).
Samples were centrifuged at 650*g for 10 minutes immediately following addition of
bacteria. Gentamicin (50 µg/ml) was added to cultures 1 hour post infection.
Assessment of bacteria burden
Mice were euthanized via i.p. injection with 2,2,2 tribromoethanol (avertin). Whole liver,
spleen and lungs were removed, wet weight assessed, homogenized in 500 µl HBSS with a
Tissue Master 125 (Omni International) and centrifuged. The resulting supernatants were
plated on LB agar plates.
Assessments of airway inflammation
Mice were euthanized via i.p. injection of avertin and serum was harvested via cardiac
puncture. The liver, kidney, and spleen were removed, weighed, and either homogenized in
500 µl HBSS or fixed in 4% paraformaldehyde (PFA). Mice were then perfused with HBSS
and a tracheal cannula was inserted below the larynx. The lungs were lavaged 5 times with 1
ml HBSS followed by centrifugation to isolate BAL cells and cell free supernatants. Red
blood cells were lysed via hypotonic saline treatment and cellularity assessed with a
hemacytometer. Aliquots of BALF were cytospun onto slides and Diff-Quik (Dade Behring)
stained for differential cell counts. Leukocytes were identified based on morphology of ≥200
cells per sample. An aliquot of BALF was plated on LB agar to assess bacteria burden. The
remaining BALF was centrifuged and the supernatant was collected. Following BALF
harvest, the lungs were fixed by inflation (20-cm pressure) and immersed in 4% PFA.
Histopathologic examination
For histopathological examination, lungs were fixed by inflation (20-cm pressure) and
immersion in 10% buffered formalin. Whole inflated lungs were embedded in paraffin wax.
Sections (4-µm) were cut and stained with hematoxylin and eosin (H&E). Serial sections of
the left lobes of the lungs that yield maximum longitudinal visualization of the
intrapulmonary main axial airway were examined and inflammation was scored by one of
the authors (I.C.A.) who was blinded to genotype and treatment. Histology images were
evaluated and each of the following inflammatory parameters was scored between 0 (absent)
and 3 (severe): mononuclear cell infiltration; polymorphonuclear cell infiltration; airway
epithelial cell hyperplasia/injury; extravasation; perivascular cuffing; and percent of lung
involved with inflammation, as previously described (35). The scores of the parameters were
averaged for a total histology score.
Cytokine and chemokine assessment
Cell free supernatants from K. pneumoniae (MOI=200, 6 hour) or S. typhi (MOI=50, 1
hour) infected thioglycolate-elicited peritoneal macrophages were analyzed using RayBio®
Cytokine Antibody Array G Series 3 (RayBiotech Inc). Axon scanner 4000B with GenePix
software was used to collect fluorescence intensities. These values were normalized to the
ratio of positive control values for each sample. Total normalized fluorescence values of
replicate spots were averaged and expressed as fold increase over non-infected samples. “N/
D” indicates cytokines where fluorescence values of replicate spots deviated more than 2
fold and were thus dismissed. If this occurred in the non-treated sample, the cytokine was
removed from the data set. Cytokine concentrations were determined by RayBiotech Inc.
using their Quantibody service.
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Samples were collected at indicated times and assayed with OptEIA Human IL-1β ELISA
Set or OptEIA Mouse IL-1β or IL-6 ELISA Sets (BD).
Cell viability determination
Viability was assayed per manufacturer protocol using either CytoTox-ONE™
Homogeneous Membrane Integrity Assay (Promega), ToxiLight® BioAssay Kit (Lonza
Bioscience), or 7-AAD (BD) staining as indicated. In the case of 7-AAD staining, cells were
collected, washed twice in PBS, resuspended in 0.5ml PBS with 1 µl 7-AAD, and incubated
for 15 minutes before analysis on a FACScan (BD).
Results
K. pneumoniae-induced cell death and IL-1β release require NLRP3 and ASC
The role of NLR proteins in host immune response to K. pneumoniae was first examined in
a human macrophage cell line. We observed both cell IL-1β release (Fig. 1A) and cell death
(Fig. 1B) following infection of THP-1 human monocytic cells with K. pneumoniae. Both
processes were abrogated in a human macrophage cell line with reduced NLRP3 expression
(Fig. 1A and 1B). Reduction of NLRP3 was achieved through stable integration of
retroviruses encoding shRNAs designed to promote the targeted degradation of NLRP3
mRNA (labeled shNLRP3), as described and demonstrated previously (8, 34).
Previously, we demonstrated that ASC, a partner protein of NLRP3, is required for S.
flexneri–induced cell death in THP-1 cells (8). Therefore, we tested the ability of Klebsiella
to elicit cell death and IL-1β in ASC-deficient THP-1 cells. Both IL-1β release and cell
death were substantially abrogated in the shASC cells (Fig. 1C and 1D). Having established
that NLRP3 is essential for Klebsiella-induced cell death, we sought to determine the nature
of this phenomenon. Indicative of pyronecrosis, K. pneumoniae-induced cell death was
markedly reduced in control THP-1 cells treated with the cathepsin-B inhibitor Ca-074-Me
(Fig. 1E). The caspase-1 specific inhibitor YVAD-cho had no effect on cell death as
measured by LDH release (Fig. 1E). The caspase-1 specific inhibitor was used at
concentrations sufficient to inhibit caspase activity, as evidenced by the attenuation of
Klebsiella-induced IL-1β release (Fig. 1F). Interestingly, the cathepsin B inhibitor not only
blocked Klebsiella-induced cell death in THP-1 cells, but also prevented IL-1β release in
response to the pathogen (Fig. 1F). This indicates that cathepsin B also controls IL-1β
release.
Additional features of Klebsiella-induced cell death are also consistent with pyronecrosis.
During apoptosis, caspase-3 undergoes activating cleavage. In turn, caspase-3 cleaves PARP
and other downstream substrates. Neither caspase-3 nor PARP were cleaved in shCTRL or
shNLRP3 cells infected with Klebsiella, though both were cleaved in staurosporine-treated
cells (Fig. 1G). During macrophage necrosis, HMGB1 is released. In accordance with this,
HMGB1 is released from K. pneumoniae infected shCTRL cells but not infected shNLRP3
cells as determined by a western blot (Fig. 1H). HMGB1 is not released by THP-1 cells
treated with staurosporine, a well-established inducer of apoptotic cell death (Fig 1H).
HMGB1 release from shCTRL cells is abrogated by a Cathepsin B inhibitor (Ca-074-Me),
indicating that Klebsiella induced HMGB1 release requires cell death (Fig 1I).
Klebsiella-induced IL-1β is reduced in Nlrp3−/− and Asc−/− macrophages
To examine the physiologic importance of these results, BMDM were isolated from WT
mice and mice deficient for Nlrp3, Asc, or Nlrc4. Deletion of Nlrp3 or Asc resulted in a near
complete inhibition of IL-1β induced by Klebsiella as measured by ELISA, whereas Nlrc4
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null macrophages demonstrated no substantial difference from WT (Fig. 2A). Importantly,
this phenomenon is not common to all pathogenic bacteria. In agreement with previous
work, IL-1β release from macrophages infected with S. typhi was unaffected by Nlrp3
deletion, whereas deletion of Nlrc4 eliminated the inflammatory response (Fig. 2A). The
NLRP3 inflammasome was previously reported to be activated by a combination of E. coli
lipopolysaccharide (LPS) and ATP (9). To determine if the NLRP3 inflammasome is also
activated by Klebsiella LPS, BMDM were challenged with 50 ng/ml LPS isolated from K.
pneumoniae for 16 hours followed by stimulation with 5 mM ATP for 20 minutes. In
contrast to WT and Nlrc4 deficient macrophages, deletion of Asc or Nlrp3 eliminated
Klebsiella LPS-induced IL-1β release (Fig. 2B). In agreement with observations in THP-1
cells, activation of the inflammasome by K. pneumoniae was abrogated by both caspase-1
specific inhibitors (YVAD) and the cathepsin B inhibitor, CA-074-Me (Fig. 2C). Together,
these results indicate that NLRP3 is the predominant NLR activated by Klebsiella and that
deletion of either Nlrp3 or Asc substantially abrogates host inflammatory responses.
K. pneumoniae induces chemotactic and inflammatory cytokine production in primary
mouse macrophages
The processing and release of proinflammatory cytokines and chemokines is fundamental to
proper innate immune response to pathogens. To more broadly assess the effect of NRLP3
and ASC on host inflammatory responses, cell free supernatants prepared from Klebsiella-
or Salmonella-infected macrophages were analyzed on anti-cytokine antibody arrays
containing antibodies to 62 inflammatory mediators. Production of IL-1β was markedly
decreased in both Asc and Nlrp3 deficient macrophages as expected, but GM-CSF and
IL-1α were also reduced indicating that these cytokines are coordinately controlled by ASC
and NRLP3 either directly or indirectly (Fig 3A). In contrast, Mip-1 was coordinately
enhanced in Nlrp3 and Asc-deficient macrophages when compared to control cells, perhaps
to compensate for the loss of IL-1β. IL-6 and RANTES were increased in the Nlrp3−/− but
not Asc−/− cells. As a pathogen-specificity control, IL-1β was not decreased in Nlrp3
deficient macrophages treated with Salmonella, which activates the Nlrc4 inflammasome.
To confirm the results obtained by the antibody array, a subset of inflammatory mediators
from K. pneumoniae challenged ex vivo macrophages were measured using quantitative
multiplexed anti-cytokine arrays. Cytokine measurements of IL-1β, Mcp-1, and KC in the
absence of Asc and Nlrp3 are consistent with the data obtained by the antibody arrays (Fig.
3B, complete data set shown in Table S1).
Mice lacking Nlrp3 and Asc demonstrate significantly increased mortality following K.
pneumoniae airway infection
Our in vitro results suggested that ASC and NRLP3 are critical regulators of K. pneumoniae
induced inflammation and cell death. To determine if inflammation was also reduced in
vivoAsc and Nlrp3 deficient mice were challenged with (7.4×104) CFUs of K. pneumoniae
delivered through airway infection. Previous reports show that E. coli LPS enhances NLRP3
expression in vitro (36). To assess this issue in animals in the context of K. pneumoniae, we
show that in vivo NRLP3 expression is greatly induced (600×) by this bacteria while ASC
expression is increased by 25× (Fig. 4A). To determine whether NRLP3 and ASC are
involved in mediating the overall host response to K. pneumoniae in vivo, animals were
challenged via intratracheal instillation and survival was assessed over the course of 4 days.
Mice lacking the Nlrp3 gene demonstrated moderate but statistically significant increased
mortality compared with WT mice (p < 0.05, Logrank Test) (Fig. 4B). Asc deficient mice
demonstrated similar increases in mortality (Fig. 4C). No significant difference in survival
was observed between Nlrc4-deficient mice and the WT controls (Fig. 4D). This moderate
effect of Nlrp3 on animal survival may be explained by other NLRs that can mediate
inflammasome formation in the lung, as well as by the compensatory increase in other
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inflammatory cytokines, such as IL-6, which might mask the effect of Nlrp3-deficiency in
animals.
Nlrp3 deficient mice demonstrate significantly attenuated airway inflammation following K.
pneumoniae infection
The above results suggested that NRLP3 is an important mediator of several inflammatory
cytokines and is essential for mouse survival in an in vivo model of K. pneumoniae
infection. To determine if airway inflammation was attenuated, Nlrp3 deficient mice were
challenged via intra-tracheal instillation with K. pneumoniae and the lungs were harvested
48 hours post inoculation for histology analysis. Lung sections were prepared to reveal the
main bronchi of the left lobe from the indicated genotypes and representative sections were
examined (10× and 20× magnification) (Fig. 5A). In comparison to WT and Nlrc4−/− mice,
Nlrp3−/− mice show decreased inflammatory cell recruitment and less occlusion of the
alveolar spaces (Fig. 5A). These findings are consistent with a significant attenuation in
airway inflammation observed in mice lacking Nlrp3, but not Nlrc4, following pulmonary
challenge with K. pneumoniae (Fig. 5B).
In vivo levels of IL-1β and cell death are reduced in K. pneumonia challenged Nlrp3−/−
mice
We have demonstrated that NLRP3 is required for necrosis in both human and mouse cell
cultures challenged with Klebsiella. We further demonstrate that NRLP3 mediates
pulmonary inflammation and protects against the bacterial infection. We next sought to
assess the in vivo relevance of this gene in cytokine production, bacterial-induced necrosis
and HMGB1 release. Processes that regulate the latter two have not been extensively studied
in an in vivo setting. To determine the physiologic effects of NRLP3, we first measured
IL-1β levels in the BALF and serum of K. pneumoniae infected mice. Deletion of Nlrp3
caused a near-abrogation of serum IL-1β, which is consistent with the important role
NRLP3 plays in IL-1β production by monocytes (Fig. 6A). Deletion of Asc also resulted in
marked decreases in circulating levels of IL-1β (Fig. 6A). IL-1β in the BALF was modestly
reduced in the Nlrp3−/− mice, a finding that is similar to other in vivo analyses (13). The
modest effect is likely due to redundant NLR proteins in the lung stroma that remained
intact in these mice. This decrease in IL-1β was accompanied by a modest increase of IL-6
observed between Nlrp3−/− and WT mice in serum and BALF samples (Fig. 6C–D), which
is consistent with the cytokine array analysis of in vitro cultured cells shown in Fig. 3. No
significant differences were observed in the cellular composition of the BALF between
genotypes (Table S2). Deletion of Nlrp3 also decreased overall levels of cell death in BALF
samples as determined by LDH release (Fig. 6E). To examine whether NRLP3 is
responsible for the induction of HMGB1, HMGB1 levels were measured in serum samples
of K.pneumoniae challenged mice. As measured by western blot analysis, Klebsiella-
induced HMGB1 release was substantially abrogated in Nlrp3−/− mice (Fig. 6F). Having
determined that NLRP3 was involved in the initiation of cell death in response to K.
pneumoniae in vivo, we sought to determine if this cell death was morphologically
consistent with necrosis. Cells collected from BALF samples obtained from K. pneumoniae
infected animals were subjected to electron microscopy analysis. Cells harvested from WT
animals demonstrate several morphological features consistent with necrosis, including loss
of plasma membrane integrity and lack of chromatin condensation (Fig. 6G). In contrast,
cells obtained from Nlrp3 deficient animals exhibit no signs of cell death, despite the
presence of several intracellular K. pneumoniae bacteria (Fig 6G). These results indicate that
Nlrp3 mediates K. pneumoniae induced inflammation and cell death in vivo, and that this
cell death is morphologically and biochemically consistent with necrosis.
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Several recent reports have established a role for NRLP3 in mediating pathogen-induced
inflammation in vitro, but the majority of evidence has been provided using ex vivo cultures
obtained from gene-deletion mice. Here, we identify NRLP3 as a critical in vivo effector of
the host immune response to K. pneumonia, a major cause of community-acquired bacterial
pneumonia. K. pneumoniae was selected for analysis because it induces a flagrant cytokine
and inflammatory response, including the release of HMGB1, and significant necrosis in the
lung, thus allowing us to assess the effect of NRLP3 and ASC on all three processes. This is
the first combined in vitro and in vivo demonstration that an NLR molecule is a key
regulator of not only IL-1β maturation, but also HMGB1 release and necrotic cell death in
response to pathogen exposure. Furthermore, these results demonstrate the in vivo
consequences of NRLP3 activity on host survival and inflammation. Despite substantial
decreases in lung inflammation and tissue destruction (as evaluated by cytokine analysis and
criteria specified in Materials and Methods), mice lacking Nlrp3 demonstrate increased
susceptibility to Klebsiella-induced lethality. This finding confirms that NRLP3 activity
contributes to protective host responses to bacterial pathogens via both inflammasome-
dependent and independent processes. This is similar to recent findings regarding the role of
NRLP3 during infection by influenza virus where the Nlrp3 gene is found to be important
for increased pulmonary inflammation, cellular infiltrate and IL-1β/IL-18 production, all of
which coincide with increased animal survival and decreased viral load (37, 38).
After S. flexneriK. pneumoniae is the second gram negative bacterial pathogen identified
which activates the NLRP3-dependent cell death program termed pyronecrosis (8). This
pathway of cell death has morphological features characteristic of necrosis, and similar to
necrosis is inherently pro-inflammatory. Cellular components spill out from the pyronecrotic
cell into the microenvironment. Among these components is HMGB1, a nuclear protein
which takes on the role of a powerful pro-inflammatory cytokine when released from the
cell (17, 39). HMGB1 stimulates the RAGE, TLR2, and TLR4 receptors on neighboring
monocytes and macrophages and results in the induction of several inflammatory cytokines,
including TNFα and IL-1β (40–42). K. pneumoniae induces a significant increase in the
systemic levels of HMGB1 in the WT mice, while no HMGB1 is observed in the serum
from Nlrp3−/− animals. This NLRP3-dependent release of HMGB1 is also observed in
human THP-1 monocytic cells challenged with Klebsiella. Caspase-1 inhibitors failed to
abrogate NLRP3-mediated HMGB1 release, suggesting that this phenomenon does not
require inflammasome activity. It should be noted that HMGB1 levels are significantly
increased in human septic patients, including those with K. pneumoniae sepsis (27).
Neutralization of HMGB1 is currently under investigation as a therapeutic target for the
intervention of sepsis, bacteremia, and induced acute respiratory distress syndrome (43, 44).
Though a broad inhibition of NLRP3-dependent responses may be detrimental to host
survival, neutralization of HMGB1 may provide an opportunity to abrogate NLRP3-
mediated sepsis or bacteremia without increasing host mortality.
Pyronecrosis serves as an interesting contrast to pyroptosis, another form of pathogen-
induced cell death (45). While pyronecrosis requires cathepsin B but not caspase activity,
pyroptosis requires the activity of caspase-1 (21). These two pathways also appear to be
induced by different stimuli and involve different NLRs. Pyronecrosis has been observed in
monocytic cells infected with 50 MOI of Shigella flexneri, an MOI previously shown to
cause necrosis (8). Pyroptosis has been observed in monocytic cells infected with
Salmonella (31, 46), Pseudomonas aeruginosa and low dose (<10 MOI) S. flexneri (31, 46–
48). Interestingly, though ASC is required for activation of caspase-1, deletion of ASC does
not abrogate caspase-1 dependent pyroptosis initiated by P. aeruginosa (47).
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Our in vitro and in vivo results indicate that NLRP3-dependent pyronecrosis is the
predominant cell death and inflammation pathway induced by Klebsiella. In contrast to the
Salmonella-induced pyroptosis pathway which is dependent on caspase-1 and NLRC4,
ablation of the Nlrc4 or caspase-1 gene has minimal effect on inflammation or cell death
induced by K. pneumoniae. Interestingly, cathepsin B inhibitors not only block NRLP3-
mediated pathogen induced cell death, but also block the induction of IL-1β maturation by
K. pneumoniae. A similar requirement for cathepsin B in NRLP3 mediated IL-1β
maturation in response to silica crystals, aluminum salts, and lysosomal permeabilization has
also been recently reported (16, 49). These finding suggests that a significant portion of K.
pneumoniae-induced IL-1β release might lie downstream of pyronecrosis, which is not
surprising given the strong pro-inflammatory activity of HMGB1.
Previously, we demonstrated that NLRP3 and ASC were required for the release of IL-1β
and HMGB1 from a human macrophage cell line, THP-1, infected with Shigella flexneri.
Here we have shown that the release of IL-1β and HMGB1 is also markedly decreased from
Nlrp3 and Asc deficient macrophages infected with K. pneumoniae and extended this
finding to a study of the whole animal. Furthermore, our results reveal additional cytokines
and chemokines, such as GM-CSF and IL-1α, which are also reduced in the absence of
Nlrp3 or Asc. Perhaps to compensate for the lack of these inflammatory mediators, the
levels of Mip-1α, IL-6, and RANTES were increased in Nlrp3−/− or Asc−/− cells. The
mechanisms by which NRLP3 and ASC regulate the production of these cytokines and
chemokines are currently under investigation, however these results demonstrate that
NRLP3 and ASC may directly or indirectly influence the inflammatory response to K.
pneumoniae, through both inflammasome dependent and independent pathways.
In summary, our results indicate that NLRP3 and ASC are key regulators of necrosis and
inflammation associated with K. pneumoniae infections in human and mouse cells. Most
important, this body of work demonstrates that altering specific NLRs can dramatically
affect the in vivo host immune response in a common and clinically relevant model of
Gram-negative bacterial pneumonia. Given the clear phenotype observed in the Nlrp3 and
Asc deficient mice, it will be interesting to further define the mechanisms underlying the
attenuation of inflammation and increased mortality, with special emphasis on the role of
HMGB1. Our findings suggest the cumulative effect of NRLP3 on cytokines and
chemokines, cell death, and HMGB1 protects the host from pathogen induced mortality.
These findings exemplify the complex interactions associated with NLRP3 in innate
immune signaling and potential limitations of therapeutic intervention of NLRP3 activity.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Klebsiella pneumoniae induced cell death and IL-1β required NLRP3 and ASC
A) K. pneumoniae induced IL-1β release was decreased in THP-1 cells stably transduced
with NLRP3-specific shRNA (shNLRP3). B) shNLRP3-THP-1 cells were resistant to K.
pneumoniae-induced death. C and D) ASC was required for K. pneumonia-induced IL-1β
release (C) and cell death (D) in THP-1 cells. E and F) Addition of 50 µM cathepsin B
inhibitor (Ca-074-Me) substantially abrogated K. pneumoniae induced cell death (E) and
IL-1β release (F) in shCTRL and shNLRP3 cells. In contrast, 100 µM caspase-1 specific
(YVAD-CHO) inhibitors failed to block K. pneumoniae-induced cell death (E), but did
inhibit IL-1β release (F). G) Caspase-3 and PARP were cleaved in response to an apoptotic
stimulus (staurosporine), but not in THP-1 cells following K. pneumoniae infection. H) K.
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pneumoniae-induced HMGB1 release was abrogated in cells deficient in NLRP3 IL-1β
release was determined by ELISA. I) Addition of 50 µM cathepsin B inhibitor (Ca-074-Me)
substantially abrogated K. pneumoniae induced HMGB1 release. Caspase-3, PARP, and
HMGB1 levels were assessed by western blot analysis. NT, no treatment; N/D, not detected.
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Figure 2. Klebisella pneumoniae induced NLRP3 and cathepsin B dependent IL-1β release in
primary macrophages
A) Nlrp3 and Asc deficient BMDM exhibited decreased levels of IL-1β release in response
to K. pneumoniae but not S. typhi. Macrophages lacking Nlrc4 demonstrated no defect in K.
pneumoniae induced IL-1β release, but IL-1β release was attenuated in response to S. typhi.
B) K. pneumoniae LPS (50 ng/ml, 16 hours) in combination with ATP (5 mM, 20 min.)
stimulated NLRP3 and ASC-dependent, but NLRC4-independent, IL-1β release from
BMDM. C) Addition of either 100 µM caspase-1 inhibitor (YVAD) or 50 µM cathepsin B
inhibitor (Ca-074-Me) substantially abrogated K. pneumoniae induced IL-1β release from
BMDM. IL-1β was measured by ELISA. NT, no treatment; N/D, none detected.
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Figure 3. Klebsiella pneumoniae induced inflammatory cytokines and chemokines in primary
macrophages
A) Thioglycolate-elicted peritoneal macrophages of indicated genotypes were infected with
K. pneumoniae (MOI=200, 6 hours) or S. typhi (MOI=50, 1 hour). Cell free supernatants
were analyzed on RayBiotech G Series 3 cytokine antibody arrays. Cytokines and
chemokines induced ≥5 fold over the non-treated control of each genotype are shown. B)
Quantification of IL-1β, MCP-1, and KC support trends observed on G Series 3 cytokine
arrays. Cytokine levels were determined using RayBiotech Quantibody service.
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Figure 4. Nlrp3 and Asc deficient mice demonstrated significantly increased mortality following
K. pneumoniae airway infection
Mice were intratracheally challenged with (7.4×104) CFUs of K. pneumoniae and survival
was assessed over the course of 4 days. A) Total RNA was extracted from whole,
homogenized lungs and expression was determined via real time PCR. NLRP3 expression is
dramatically increased 48 hours post K. pneumoniae infection. B and C) Mice lacking Nlrp3
(B) or Asc C) demonstrated significantly increased mortality compared with wild type (WT)
mice (p < 0.05, Logrank Test). D) No significant difference in survival was observed
between WT mice and animals lacking Nlrc4 following K. pneumoniae challenge. Mock: n
= 7; Nlrp3−/−: n = 11; Asc−/−: n = 4; Nlrc4−/−: n = 7; WT: n = 19
Willingham et al. Page 17













Figure 5. Nlrp3 deficient mice demonstrated significantly attenuated airway inflammation
following Klebsiella pneumoniae infection
A) In comparison to WT and Nlrc4 deficient mice, mice lacking Nlrp3 showed decreased
inflammatory cell recruitment and less occlusion of the alveolar spaces following K.
pneumoniae infection. Mice were challenged with 7.4×104 CFUs of K. pneumoniae. Whole
lungs were harvested 48 hrs post-infection and each lobe was assessed and scored at specific
locations along the main bronchi. Representative histology sections from the apical region of
the main bronchi of the large lobe (10× magnification) are shown. B) Histology images were
evaluated for a variety of inflammatory parameters and scored between 0 (absent) and 3
(severe). Significant attenuation in airway inflammation was observed in K. pneumoniae
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challenged mice lacking Nlrp3 p < 0.05). Mock, n=3; Nlrp3−/−, n=6; Nlrc4−/−, n=6; WT,
n=12.
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Figure 6. NRLP3 regulated Klebsiella pneumoniae induced IL-1β and necrotic cell death in vivo
A) Serum levels of IL-1β were significantly reduced in both Nlrp3 and Asc deficient mice
challenged with K. pneumoniae p<0.05). B) A modest, yet significant, decrease in K.
pneumoniae induced IL-1β was observed in the BALF of Nlrp3−/− mice compared to WT
(p<0.05). In contrast, IL-6 levels were elevated in the serum (C) and BALF (D) of Nlrp3−/−
mice following K pneumoniae infection. IL-1β and IL-6 were measured by ELISA. E)
Decreased levels of cell death were detected in the BALF of K. pneumoniae infected Nlrp3
deficient mice as determined by LDH release. F) Serum levels of HMGB1 were
dramatically reduced in mice lacking Nlrp3 as determined by western blot analysis. G) Cells
obtained by BALF were collected from K. pneumoniae challenged WT and Nlrp3 deficient
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animals and were subjected to electron microscopy analysis. Cells from WT mice exhibited
cell death features morphologically consistent with necrosis. In contrast, cells obtained from
Nlrp3 deficient animals did not exhibit a morphology indicative of cell death. Magnified
intracellular K. pneumoniae are shown in insets.
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